Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DCI-Biolafitte is a leading manufacturer of bioreactors and fermentors for the biotechnology and pharmaceutical industries. Formed as a partnership between the US-based DCI, Inc. and the French company Pierre Guerin, it integrates advanced European engineering with American manufacturing excellence. The company provides a comprehensive range of stainless steel and single-use systems, from benchtop laboratory units to large-scale industrial production vessels up to 50,000 liters. Their product portfolio includes the BioPro and BioCell series, as well as control retrofits, vessel upgrades, and specialized agitation systems. DCI-Biolafitte also offers extensive field services, including onsite fabrication, maintenance, and validation support to ensure cGMP compliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DCI-Biolafitte.